For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Hoth Therapeutics Inc’s stock clocked out at $0.93, down -2.47% from its previous closing price of $0.95. In other words, the price has decreased by -$2.47 from its previous closing price. On the day, 1.2 million shares were traded.
Ratios:
To gain a deeper understanding of HOTH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.20 and its Current Ratio is at 9.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, The Benchmark Company on October 15, 2019, initiated with a Speculative Buy rating and assigned the stock a target price of $10.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 16 ’24 when Knie Robb bought 25,000 shares for $0.67 per share. The transaction valued at 16,750 led to the insider holds 58,131 shares of the business.
Stock Price History:
Over the past 52 weeks, HOTH has reached a high of $3.80, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -1.91%, while the 200-Day Moving Average is calculated to be -1.24%.
Shares Statistics:
A total of 13.17M shares are outstanding, with a floating share count of 13.11M. Insiders hold about 0.49% of the company’s shares, while institutions hold 1.85% stake in the company.
